Publications by: Alison Haywood

Also publishes as (A. Haywood)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0 [feed] RSS 2.0
Number of items: 28.

Aouira, Nisreen, Khan, Sohil, McDermott, Brett, Heussler, Helen, Haywood, Alison, Karaksha, Abdullah, and Bor, William (2020) Paper based vs. electronic records for clinical audit: evidence of documentation of medication safety monitoring in youth prescribed antipsychotics. Children and Youth Services Review, 109. 104666.

Hambly , Jessica L., Khan, Sohil, McDermott, Brett, Bor, William, and Haywood, Alison (2016) Pharmacotherapy of conduct disorder: challenges, options and future directions. Journal of Psychopharmacology, 30 (10). pp. 967-975.

Redmayne, Nichola, Robertson, Sherryl, Kockler, Jutta, Llewelyn, Victoria, Haywood, Alison, and Glass, Beverley (2015) Repackaged sodium valproate tablets: meeting quality and adherence to ensure seizure control. Seizure, 31. pp. 108-111.

Kockler, Jutta, Robertson, Sherryl, Hope, Denise, Haywood, Alison, and Glass, Beverley D (2014) Stability of paracetamol tablets repackaged in dose administration aids for prn use: implications for practice. Australian Journal of Pharmacy, 95. pp. 56-58.

Robertson, Sherryl, Kockler, Jutta, Haywood, Alison, and Glass, Beverley D. (2014) Common medicines for PRN use: stability considerations in DAAs. Australian Journal of Pharmacy, 95. pp. 56-59.

Haywood, Alison, and Glass, Beverley (2014) Formulation and stability of oral liquids: an evolving research and skill base in compounding. In: Abstracts from the Australasian Pharmaceutical Sciences Association Conference. P182. From: APSA 2014: Australasian Pharmaceutical Sciences Association Conference, 5-7 December 2014, Brisbane, QLD, Australia.

Haywood, Alison, and Glass, Beverley (2013) Anti-inflammatory preparations for rheumatology. Australian Pharmacist, 32 (1). pp. 58-61.

Haywood, Alison, and Glass, Beverley D. (2013) Liquid dosage forms extemporaneously prepared from commercially available products: considering new evidence on stability. Journal of Pharmacy & Pharmaceutical Sciences, 16 (3). pp. 441-455.

Haywood, Alison, and Glass, Beverley (2012) Treatment of tritrichomonas foetus infection in cats. Australian Pharmacist, 31 (2). pp. 138-141.

Haywood, Alison, and Glass, Beverley (2011) Nifedipine for the treatment of chilblains. Australian Pharmacist, 30 (8). pp. 664-668.

Haywood, Alison, and Glass, Beverley (2011) Pharmaceutical excipients: where do we begin? Australian Prescribing, 34 (4). pp. 112-114.

Glass, Beverley, and Haywood, Alison (2011) Historical extemporaneous formulae: what are the risks? Australian Pharmacist, 30 (7). pp. 553-554.

Haywood, Alison, and Glass, Beverley (2011) Methimazole for feline hyperthyroidism. Australian Pharmacist, 30 (7). pp. 574-578.

Glass, Beverley D., Haywood, Alison, Khar, Roop K., and Garg, Sanjay (2011) Advanced drug-delivery systems. In: Garg, Sanjay, (ed.) MCQs in Pharmaceutical Science and Technology. Pharmaceutical Press, London, UK, pp. 171-218.

Haywood, A., Llewelyn, V., Robertson, S., Mylrea, M., and Glass, B. (2011) Dose administration aids: pharmacists' role in improving patient care. Australasian Medical Journal, 4 (4). pp. 183-189.

Haywood, Alison, Glass, Beverley D., Jones, David S., and Garg, Sanjay (2011) Particle science and calculations. In: Garg, Sanjay, (ed.) MCQs in Pharmaceutical Science and Technology. Pharmaceutical Press, London, UK, pp. 87-130.

Perumal, Omathanu P., Haywood, Alison, Glass, Beverley, and Ho, Paul Chi-Lui (2011) Pharmacokinetics and biopharmaceutics. In: Garg, Sanjay, (ed.) MCQs in Pharmaceutical Science and Technology. Pharmaceutical Press, London, UK, pp. 41-86.

Haywood, Alison, and Glass, Beverley (2010) Men's health and the treatment of andropause. Australian Pharmacist, 29 (5). pp. 406-410.

Haywood, Alison, and Glass, Beverley (2010) Paediatric mixtures. Australian Pharmacist, 29 (4). pp. 316-320.

Haywood, Alison, and Glass, Beverley (2010) Compounding for analgesia. Australian Pharmacist, 29 (1). pp. 45-48.

Haywood, Alison, and Glass, Beverley (2009) Modifying oral cytotoxics: what are the considerations? Australian Pharmacist, 28 (8). pp. 674-677.

Glass, B., Mangan, M., and Haywood, A. (2009) Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of quality? Journal of Clinical Pharmacy and Therapeutics, 34 (2). pp. 161-169.

Glass, Beverley Dawn, Haywood, Alison, Llewelyn, Victoria, and Mangan, Martina (2009) Compliance aids and medicine stability: new evidence of quality assurance. Current Drug Safety, 4 (1). pp. 74-78.

Bowen, Luke, Mangan, Martina, Haywood, Alison, and Glass, Beverley (2007) Stability of frusemide tablets repackaged in dose administration aids. Journal of Pharmacy Practice and Research, 37 (3). pp. 178-181.

Haywood, Alison, and Glass, Beverley (2007) Managing extemporaneous oral liauids in practice. Journal of Pharmacy Practice and Research, 37 (2). pp. 131-133.

Haywood, Alison, Mangan, Martina, and Glass, Beverley (2006) Stability implications of repackaging paracetamol tablets into dose administration aids. Journal of Pharmacy Practice and Research, 36 (1). pp. 25-28.

Glass, Beverley D., and Haywood, Alison (2006) Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products. Journal of Pharmacy & Pharmaceutical Sciences, 9 (3). pp. 398-426.

Haywood, Alison, Mangan, Martina, Grant, Gary, and Glass, Beverley (2005) Extemporaneous isoniazid mixture: stability implications. Journal of Pharmacy Practice and Research, 35 (3). pp. 181-182.

This list was generated on Thu Nov 28 01:00:54 2024 AEST.